Kiniksa Pharmaceuticals, Ltd.Kiniksa Pharmaceuticals, Ltd.Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals, Ltd.

No trades
See on Supercharts

Price target

36.000.000.00%
The 6 analysts offering 1 year price forecasts for KNSA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to KNSA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


KNSA EPS for the last quarter is −0.18 USD despite the estimation of 0.02 USD. In the next quarter EPS is expected to reach 0.03 USD. Track more of Kiniksa Pharmaceuticals, Ltd. financials and stay on top of what is up with the company.
In the next quarter Kiniksa Pharmaceuticals, Ltd. revenue is expected to reach ‪123.27 M‬ USD. Check out Kiniksa Pharmaceuticals, Ltd. revenue and earnings and make informed decisions.
According to analysts, KNSA price target is 36.00 USD with a max estimate of 40.00 USD and a min estimate of 32.00 USD. Check if this forecast comes true in a year, meanwhile watch Kiniksa Pharmaceuticals, Ltd. stock price chart and keep track of the current situation with KNSA news and stock market news.
We've gathered opinions of 6 analysts rating KNSA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.